4D Molecular Therapeutics, Inc. (FDMT)

4D Molecular Therapeutics Revenue

In the year 2025, 4D Molecular Therapeutics had annual revenue of $85.21M with 230,194.59% growth. 4D Molecular Therapeutics had revenue of $85.09M in the quarter ending December 31, 2025, with 8,508,900.00% growth.

• Revenue (ttm): $85.21M
• Revenue Growth: +230,194.59%
• P/S Ratio: 5.92
• Revenue / Employee: $434,740
• Employees: 196
• Market Cap: 535.53M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	85.21M	85.17M	230,194.59%
Dec 31, 2024	37.00K	-20.69M	-99.82%
Dec 31, 2023	20.72M	17.59M	562.29%
Dec 31, 2022	3.13M	-14.91M	-82.65%
Dec 31, 2021	18.04M	4.43M	32.52%
Dec 31, 2020	13.61M	6.63M	94.85%
Dec 31, 2019	6.99M	-7.14M	-50.56%
Dec 31, 2018	14.13M	8.34M	144.04%
Dec 31, 2017	5.79M	-	-